ID   ATTY_RAT                Reviewed;         454 AA.
AC   P04694; Q5EBB6;
DT   13-AUG-1987, integrated into UniProtKB/Swiss-Prot.
DT   13-AUG-1987, sequence version 1.
DT   29-MAY-2024, entry version 174.
DE   RecName: Full=Tyrosine aminotransferase;
DE            Short=TAT;
DE            EC=2.6.1.5;
DE   AltName: Full=L-tyrosine:2-oxoglutarate aminotransferase;
GN   Name=Tat;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND ACETYLATION AT MET-1.
RX   PubMed=2863382; DOI=10.1016/0022-2836(85)90386-9;
RA   Grange T., Guenet C., Dietrich J.-B., Chasserot S., Fromont M., Befort N.,
RA   Jami J., Beck G., Pictet R.;
RT   "Complete complementary DNA of rat tyrosine aminotransferase messenger RNA.
RT   Deduction of the primary structure of the enzyme.";
RL   J. Mol. Biol. 184:347-350(1985).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, COFACTOR, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=2562840; DOI=10.1016/s0021-9258(17)31222-x;
RA   Hargrove J.L., Scoble H.A., Mathews W.R., Baumstark B.R., Biemann K.;
RT   "The structure of tyrosine aminotransferase. Evidence for domains involved
RT   in catalysis and enzyme turnover.";
RL   J. Biol. Chem. 264:45-53(1989).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Liver;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 190-386.
RC   TISSUE=Liver;
RX   PubMed=1983704; DOI=10.3109/10425179009016044;
RA   Morozov I.V.;
RT   "Nucleotide sequence of rat liver tyrosine aminotransferase gene
RT   fragment.";
RL   DNA Seq. 1:151-155(1990).
RN   [5]
RP   PARTIAL PROTEIN SEQUENCE, FUNCTION, CATALYTIC ACTIVITY, COFACTOR,
RP   BIOPHYSICOCHEMICAL PROPERTIES, AND SUBUNIT.
RX   PubMed=1682164; DOI=10.1016/0014-5793(91)81317-2;
RA   Lorber B., Dietrich J.-B., Kern D.;
RT   "Isolation and characterization of active N-terminal truncated apo- and
RT   holoenzyme of mammalian liver tyrosine aminotransferase.";
RL   FEBS Lett. 291:345-349(1991).
RN   [6]
RP   STRUCTURAL PROPERTIES.
RX   PubMed=2901862; DOI=10.1016/0300-9084(88)90252-0;
RA   Dietrich J.-B., Genot G., Beck G.;
RT   "Structural and immunochemical properties of rat liver tyrosine
RT   aminotransferase.";
RL   Biochimie 70:673-679(1988).
CC   -!- FUNCTION: Transaminase involved in tyrosine breakdown. Converts
CC       tyrosine to p-hydroxyphenylpyruvate. Can catalyze the reverse reaction,
CC       using glutamic acid, with 2-oxoglutarate as cosubstrate (in vitro). Has
CC       much lower affinity and transaminase activity towards phenylalanine.
CC       {ECO:0000269|PubMed:1682164}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + L-tyrosine = 3-(4-hydroxyphenyl)pyruvate + L-
CC         glutamate; Xref=Rhea:RHEA:15093, ChEBI:CHEBI:16810,
CC         ChEBI:CHEBI:29985, ChEBI:CHEBI:36242, ChEBI:CHEBI:58315; EC=2.6.1.5;
CC         Evidence={ECO:0000269|PubMed:1682164};
CC   -!- COFACTOR:
CC       Name=pyridoxal 5'-phosphate; Xref=ChEBI:CHEBI:597326;
CC         Evidence={ECO:0000269|PubMed:1682164, ECO:0000269|PubMed:2562840};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=2.2 mM for tyrosine {ECO:0000269|PubMed:1682164};
CC   -!- PATHWAY: Amino-acid degradation; L-phenylalanine degradation;
CC       acetoacetate and fumarate from L-phenylalanine: step 2/6.
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:1682164}.
CC   -!- TISSUE SPECIFICITY: Liver.
CC   -!- SIMILARITY: Belongs to the class-I pyridoxal-phosphate-dependent
CC       aminotransferase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X02741; CAA26519.1; -; mRNA.
DR   EMBL; M18340; AAA42203.1; -; mRNA.
DR   EMBL; BC089813; AAH89813.1; -; mRNA.
DR   EMBL; X15690; CAA33725.1; -; Genomic_DNA.
DR   PIR; A23310; XNRTY.
DR   RefSeq; NP_036800.1; NM_012668.2.
DR   AlphaFoldDB; P04694; -.
DR   SMR; P04694; -.
DR   STRING; 10116.ENSRNOP00000022721; -.
DR   BindingDB; P04694; -.
DR   ChEMBL; CHEMBL5947; -.
DR   iPTMnet; P04694; -.
DR   PhosphoSitePlus; P04694; -.
DR   PaxDb; 10116-ENSRNOP00000022721; -.
DR   Ensembl; ENSRNOT00000022721.5; ENSRNOP00000022721.2; ENSRNOG00000016348.5.
DR   Ensembl; ENSRNOT00055036557; ENSRNOP00055029703; ENSRNOG00055021389.
DR   Ensembl; ENSRNOT00060021944; ENSRNOP00060017361; ENSRNOG00060012900.
DR   Ensembl; ENSRNOT00065019534; ENSRNOP00065014970; ENSRNOG00065012011.
DR   GeneID; 24813; -.
DR   KEGG; rno:24813; -.
DR   UCSC; RGD:3820; rat.
DR   AGR; RGD:3820; -.
DR   CTD; 6898; -.
DR   RGD; 3820; Tat.
DR   eggNOG; KOG0259; Eukaryota.
DR   GeneTree; ENSGT00940000156704; -.
DR   HOGENOM; CLU_017584_4_2_1; -.
DR   InParanoid; P04694; -.
DR   OMA; CALDLCI; -.
DR   OrthoDB; 5474881at2759; -.
DR   PhylomeDB; P04694; -.
DR   TreeFam; TF105999; -.
DR   BioCyc; MetaCyc:MONOMER-15101; -.
DR   BRENDA; 2.6.1.5; 5301.
DR   Reactome; R-RNO-8963684; Tyrosine catabolism.
DR   SABIO-RK; P04694; -.
DR   UniPathway; UPA00139; UER00338.
DR   PRO; PR:P04694; -.
DR   Proteomes; UP000002494; Chromosome 19.
DR   Bgee; ENSRNOG00000016348; Expressed in liver and 6 other cell types or tissues.
DR   GO; GO:0016597; F:amino acid binding; IDA:RGD.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0004838; F:L-tyrosine:2-oxoglutarate aminotransferase activity; IDA:RGD.
DR   GO; GO:0030170; F:pyridoxal phosphate binding; IEA:InterPro.
DR   GO; GO:0006103; P:2-oxoglutarate metabolic process; ISO:RGD.
DR   GO; GO:0006520; P:amino acid metabolic process; IDA:RGD.
DR   GO; GO:0009058; P:biosynthetic process; IEA:InterPro.
DR   GO; GO:0006536; P:glutamate metabolic process; ISS:UniProtKB.
DR   GO; GO:0006559; P:L-phenylalanine catabolic process; IBA:GO_Central.
DR   GO; GO:0071548; P:response to dexamethasone; IEP:RGD.
DR   GO; GO:0051384; P:response to glucocorticoid; IDA:RGD.
DR   GO; GO:0046689; P:response to mercury ion; IDA:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; IDA:RGD.
DR   GO; GO:0006979; P:response to oxidative stress; IDA:RGD.
DR   GO; GO:0006572; P:tyrosine catabolic process; ISS:UniProtKB.
DR   CDD; cd00609; AAT_like; 1.
DR   Gene3D; 3.90.1150.10; Aspartate Aminotransferase, domain 1; 1.
DR   Gene3D; 3.40.640.10; Type I PLP-dependent aspartate aminotransferase-like (Major domain); 1.
DR   InterPro; IPR004839; Aminotransferase_I/II.
DR   InterPro; IPR004838; NHTrfase_class1_PyrdxlP-BS.
DR   InterPro; IPR015424; PyrdxlP-dep_Trfase.
DR   InterPro; IPR015421; PyrdxlP-dep_Trfase_major.
DR   InterPro; IPR015422; PyrdxlP-dep_Trfase_small.
DR   InterPro; IPR011715; Tyr_aminoTrfase_ubiquitination.
DR   InterPro; IPR005958; TyrNic_aminoTrfase.
DR   InterPro; IPR005957; Tyrosine_aminoTrfase.
DR   NCBIfam; TIGR01264; tyr_amTase_E; 1.
DR   NCBIfam; TIGR01265; tyr_nico_aTase; 1.
DR   PANTHER; PTHR45744; TYROSINE AMINOTRANSFERASE; 1.
DR   PANTHER; PTHR45744:SF2; TYROSINE AMINOTRANSFERASE; 1.
DR   Pfam; PF00155; Aminotran_1_2; 1.
DR   Pfam; PF07706; TAT_ubiq; 1.
DR   PIRSF; PIRSF000517; Tyr_transaminase; 1.
DR   SUPFAM; SSF53383; PLP-dependent transferases; 1.
DR   PROSITE; PS00105; AA_TRANSFER_CLASS_1; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Aminotransferase; Direct protein sequencing;
KW   Phenylalanine catabolism; Phosphoprotein; Pyridoxal phosphate;
KW   Reference proteome; Transferase; Tyrosine catabolism.
FT   CHAIN           1..454
FT                   /note="Tyrosine aminotransferase"
FT                   /id="PRO_0000123889"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000269|PubMed:2863382"
FT   MOD_RES         280
FT                   /note="N6-(pyridoxal phosphate)lysine"
FT                   /evidence="ECO:0000269|PubMed:2562840"
FT   MOD_RES         448
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P17735"
FT   CONFLICT        59..60
FT                   /note="IV -> KT (in Ref. 2; AAA42203)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        209..210
FT                   /note="TA -> LE (in Ref. 2; AAA42203)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        285
FT                   /note="P -> L (in Ref. 4; CAA33725)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        304
FT                   /note="Missing (in Ref. 4; CAA33725)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        359..360
FT                   /note="AI -> DL (in Ref. 2; AAA42203)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        445
FT                   /note="A -> D (in Ref. 2; AAA42203)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   454 AA;  50635 MW;  835EBE0D2476AF71 CRC64;
     MDSYVIQTDV DDSLSSVLDV HVNIGGRNSV QGRKKGRKAR WDVRPSDMSN KTFNPIRAIV
     DNMKVQPNPN KTVISLSIGD PTVFGNLPTD PEVTQAMKDA LDSGKYNGYA PSIGYLSSRE
     EVASYYHCHE APLEAKDVIL TSGCSQAIEL CLAVLANPGQ NILIPRPGFS LYRTLAESMG
     IEVKLYNLLP EKSWEIDLKQ LESLIDEKTA CLVVNNPSNP CGSVFSKRHL QKILAVAERQ
     CVPILADEIY GDMVFSDCKY EPLANLSTNV PILSCGGLAK RWLVPGWRLG WILIHDRRDI
     FGNEIRDGLV KLSQRILGPC TIVQGALKSI LQRTPQEFYH DTLSFLKSNA DLCYGALAAI
     PGLQPVRPSG AMYLMVGIEM EHFPEFENDV EFTERLIAEQ AVHCLPATCF EYPNFFRVVI
     TVPEVMMLEA CSRIQEFCEQ HYHCAEGSQE ECDK
//
